| Bioactivity | M56-S2 iodide is a SARS-CoV-2 Mpro inhibitor (IC50=4.0 μM). M56-S2 iodide showed good oral bioavailability and low toxicity in ADMET prediction. M56-S2 iodide has good drug potential and can be used in antiviral (such as SARS-CoV-2) research[1]. |
| Target | IC50: 4.0 μM (SARS-CoV-2 Mpro). |
| Name | M56-S2 iodide |
| CAS | 1101867-17-7 |
| Formula | C17H18IN3O2 |
| Molar Mass | 423.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiaodong Dou, et al. Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation. Bioorg Med Che. 2023 Dec 15:129547. |
M56-S2 iodide
CAS: 1101867-17-7 F: C17H18IN3O2 W: 423.25
M56-S2 iodide is a SARS-CoV-2 Mpro inhibitor (IC50=4.0 μM). M56-S2 iodide showed good oral bioavailability and low toxi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.